A novel mutation in the C3 gene and recurrent invasive pneumococcal infection: a clue for vaccine development.

[1]  D. Goldblatt,et al.  Circulating pneumococcal specific plasma and memory B cells in the elderly two years after pneumococcal conjugate versus polysaccharide vaccination. , 2010, Vaccine.

[2]  M. Roediger,et al.  A randomized clinical trial comparing revaccination with pneumococcal conjugate vaccine to polysaccharide vaccine among HIV-infected adults. , 2010, The Journal of infectious diseases.

[3]  E. Mulholland,et al.  Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccine. , 2010, The Journal of allergy and clinical immunology.

[4]  C. Katlama,et al.  Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  H. Einsele,et al.  Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trial. , 2010, Vaccine.

[6]  C. Whitney,et al.  Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = years. , 2010, The Journal of infectious diseases.

[7]  M. Lipsitch,et al.  The role of complement in innate and adaptive immunity to pneumococcal colonization and sepsis in a murine model. , 2010, Vaccine.

[8]  R. Malley.  Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development , 2010, Journal of Molecular Medicine.

[9]  A. Salar,et al.  An Observational Study of Anaemia Management in Patients with NHL Receiving CHOP-14 or -21 (With or Without Rituximab) , 2008 .

[10]  D. Gerlier,et al.  Human C3 Deficiency Associated with Impairments in Dendritic Cell Differentiation, Memory B Cells, and Regulatory T Cells1 , 2008, The Journal of Immunology.

[11]  C. Katlama,et al.  Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults , 2007, AIDS.

[12]  I. Deary,et al.  Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.

[13]  O. Nadiv,et al.  Decreased induction of IL-1beta in fibroblast-like synoviocytes: a possible regulatory mechanism maintaining joint homeostasis. , 2007, Molecular immunology.

[14]  A. Caudy,et al.  Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. , 2006, Journal of the American Society of Nephrology : JASN.

[15]  R. Vaughan,et al.  Influence of donor C3 allotype on late renal-transplantation outcome. , 2006, The New England journal of medicine.

[16]  J. Goodship,et al.  Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome. , 2005, Journal of the American Society of Nephrology : JASN.

[17]  M. Lipsitch,et al.  CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  W. Fridman,et al.  Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome , 2004, Journal of Medical Genetics.

[19]  G. Deschênes,et al.  Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases. , 2004, Journal of the American Society of Nephrology : JASN.

[20]  M. Nakagawa,et al.  Molecular analysis of hereditary deficiency of the third component of complement (C3) in two sisters. , 2001, Internal medicine.

[21]  S. Black,et al.  Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. , 1999, The Pediatric infectious disease journal.

[22]  M. Lokki,et al.  Inherited complement C3 deficiency: reduced C3 mRNA and protein levels in a Laotian kindred. , 1996, Clinical immunology and immunopathology.

[23]  Y. Katz,et al.  IL‐13 results in differential regulation of the complement proteins C3 and factor B in tumour necrosis factor (TNF)‐stimulated fibroblasts , 1995, Clinical and experimental immunology.

[24]  Z. Fishelson,et al.  Inherited human complement C3 deficiency. An amino acid substitution in the beta-chain (ASP549 to ASN) impairs C3 secretion. , 1994, The Journal of biological chemistry.

[25]  M. Botto,et al.  Homozygous hereditary C3 deficiency due to a partial gene deletion. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Daha,et al.  An association between homozygous C3 deficiency and low levels of anti‐pneumococcal capsular polysaccharide antibodies , 1992, Clinical and experimental immunology.

[27]  M. Botto,et al.  Molecular basis of hereditary C3 deficiency. , 1990, The Journal of clinical investigation.

[28]  R. Strunk,et al.  Synovial fibroblast-like cells synthesize seven proteins of the complement system. , 1988, Arthritis and rheumatism.

[29]  E. Reis,et al.  Nonsense-codon-mediated decay in human hereditary complement C3 deficiency , 2003, Immunogenetics.

[30]  Z. Fishelson,et al.  Compound heterozygous complement C3 deficiency. , 1995, Immunology.

[31]  D. Houghton,et al.  Inherited C3 deficiency with recurrent infections and glomerulonephritis. , 1988, American journal of diseases of children.